Abstract
Background The initial outbreak of COVID-19 caused by SARS-CoV-2 in China in 2019 has been severely tested in other countries worldwide. We aimed to describe the spatial distribution of the COVID-19 pandemic worldwide and assess the effects of various socio-ecological factors on COVID-19 risk.
Methods We collected COVID-19 pandemic infection data and social-ecological data of 178 countries/regions worldwide from three database. We used spatial econometrics method to assess the global and local correlation of COVID-19 risk indicators for COVID-19. To estimate the adjusted incidence rate ratio (IRR), we modelled negative binomial regression analysis with spatial information and socio-ecological factors.
Findings The study indicated that 37, 29 and 39 countries/regions were strongly opposite from the IR, CMR and DCI index “spatial autocorrelation hypothesis”, respectively. The IRs were significantly positively associated with GDP per capita, the use of at least basic sanitation services and social insurance program coverage, and were significantly negatively associated with the proportion of the population spending more than 25% of household consumption or income on out-of-pocket health care expenses and the poverty headcount ratio at the national poverty lines. The CMR was significantly positively associated with urban populations, GDP per capita and current health expenditure, and was significantly negatively associated with the number of hospital beds, number of nurses and midwives, and poverty headcount ratio at the national poverty lines. The DCI was significantly positively associated with urban populations, population density and researchers in R&D, and was significantly negatively associated with the number of hospital beds, number of nurses and midwives and poverty headcount ratio at the national poverty lines. We also found that climatic factors were not significantly associated with COVID-19 risk.
Conclusion Countries/regions should pay more attention to controlling population flow, improving diagnosis and treatment capacity, and improving public welfare policies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
D.S., Y.C.C., M.T. and Y.F.Z. are funded by National Natural Science Foundation of China (No. 71473096; No. 71673101; No. 71974066). X.Y.Z is funded by Michigan Institute for Clinical and Health Research (MICHR No. UL1TR002240).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data used for the analyses are publicly available from the Johns Hopkins University Center for Systems Science and Engineering (https://github.com/CSSEGISandData/COVID-19), the World Bank (https://datacatalog.worldbank.org/dataset/world-development-indicators) and National Oceanic and Atmospheric Administration, Department of Commerce (https://catalog.data.gov/dataset/global-surface-summary-of-the-day-gsod).
https://github.com/CSSEGISandData/COVID-19
https://datacatalog.worldbank.org/dataset/world-development-indicators
https://catalog.data.gov/dataset/global-surface-summary-of-the-day-gsod